Suven Life Sciences Ltd
SUVENSuven Life Sciences Ltd
SUVENPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-29.23 | 11.37 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
46.01 | 6.09 | 0.55% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Suven Life Sciences Limited is a bio-pharmaceutical company, engaged in the business of manufacture and sale of bulk drugs and intermediaries.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 518.81 | 564.62 | 648.53 | 312.92 | 28.45 | 21.23 | 17.16 | 27.99 | 40.28 | 40.29 | ||||||||||
Raw Materials | 178.45 | 154.81 | 176.16 | 79.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 139.69 | ||||||||||
Power & Fuel Cost | 29.32 | 31.50 | 33.56 | 19.37 | 1.63 | 0.00 | 0.00 | 0.00 | 0.26 | |||||||||||
Employee Cost | 40.94 | 52.17 | 61.27 | 36.49 | 17.41 | 18.53 | 21.02 | 18.62 | 18.99 | |||||||||||
Selling & Administrative Expenses | 113.67 | 124.44 | 117.18 | 136.02 | 107.88 | 73.85 | 109.14 | 118.13 | 117.48 | |||||||||||
Operating & Other expenses | 35.48 | 51.54 | 38.89 | 28.56 | 3.21 | 1.04 | 3.93 | 2.55 | 2.83 | |||||||||||
EBITDA | 120.95 | 150.16 | 221.47 | 12.86 | -101.68 | -72.19 | -116.93 | -111.31 | -99.28 | -99.40 | ||||||||||
Depreciation/Amortization | 17.50 | 21.41 | 21.31 | 10.79 | 4.17 | 4.35 | 4.39 | 6.54 | 6.50 | 6.50 | ||||||||||
PBIT | 103.45 | 128.75 | 200.16 | 2.07 | -105.85 | -76.54 | -121.32 | -117.85 | -105.78 | -105.90 | ||||||||||
Interest & Other Items | 5.88 | 5.68 | 4.63 | 1.91 | 0.55 | 0.94 | 0.67 | 0.41 | 0.30 | 0.16 | ||||||||||
PBT | 97.57 | 123.07 | 195.53 | 0.16 | -106.40 | -77.48 | -121.99 | -118.26 | -106.08 | -106.06 | ||||||||||
Taxes & Other Items | 25.73 | 35.88 | 71.84 | 24.06 | -12.18 | -5.32 | 0.00 | 0.00 | -1.00 | -1.00 | ||||||||||
Net Income | 71.84 | 87.19 | 123.69 | -23.90 | -94.22 | -72.16 | -121.99 | -118.26 | -105.08 | -105.06 | ||||||||||
EPS | 0.26 | 0.32 | 0.45 | -0.09 | -0.65 | -5.22 | -8.25 | -6.29 | -4.82 | -4.82 | ||||||||||
DPS | 0.09 | 0.05 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.35 | 0.15 | 0.15 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Investor Presentation
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Suven Life Sciences Ltd | -29.22 | 11.37 | — |
Sun Pharmaceutical Industries Ltd | 41.74 | 5.96 | 0.81% |
Zydus Lifesciences Ltd | 31.44 | 5.49 | 0.25% |
Cipla Ltd | 29.39 | 5.11 | 0.87% |
Price Comparison
Compare SUVEN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Suven Life Sciences Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Quant Business Cycle Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4674% | Percentage of the fund’s portfolio invested in the stock 1.12% | Change in the portfolio weight of the stock over the last 3 months -0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 26/54 (0) |
Quant Healthcare Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2844% | Percentage of the fund’s portfolio invested in the stock 2.89% | Change in the portfolio weight of the stock over the last 3 months -0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 16/33 (-4) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
SUVEN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateFeb 17, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Feb 17, 2021
Cash Dividend
Ex DateEx DateFeb 14, 2019
Dividend/Share
₹1.50
Ex DateEx Date
Feb 14, 2019
Cash Dividend
Ex DateEx DateFeb 6, 2018
Dividend/Share
₹1.50
Ex DateEx Date
Feb 6, 2018
Cash Dividend
Ex DateEx DateFeb 8, 2017
Dividend/Share
₹1.00
Ex DateEx Date
Feb 8, 2017
Cash Dividend
Ex DateEx DateMar 14, 2016
Dividend/Share
₹1.00
Ex DateEx Date
Mar 14, 2016
Angel One, Reliance Power, Motherson Wiring, Olectra Green — Buy, Sell Or Hold? AskProfit
Q4 Review | Suven Life Sciences’ Q4 Report Card & FY24 Projections
Suven Life Sciences breathes new life into drug discovery plans
RIL-backed co, new-age techies among 41 firms to post losses for 4 straight quarters
Advent closes in on Suven Pharma buyout
Tech Query: Is the trend in Tech Mahindra reversing?
Suven Life Science rights issue: Record date announced. 5 things you should know
Suven Life gains after unveiling terms of rights issue
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -33.64%, vs industry avg of 8.96%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.14% to 0.01%